Seeking to improve the lives of sickle cell anemia sufferers around the world, researchers from the La Jolla Institute for Allergy and Immunology, the Dana-Farber/Children's Hospital Cancer Center in Boston and the BloodCenter of Wisconsin in Milwaukee and others are preparing to launch Phase II...
Researchers at Moffitt Cancer Center say identifying and selecting participants for phase II cancer clinical trials from a centralized warehouse of patient-donated biological data expedites participant accrual, reduces trial size, saves money, and may speed test drugs through the drug...
A malarial drug is showing promise in stopping breast cancer before it starts, Mason researchers are discovering during a clinical trial. "The bold long-term goal is a short-term oral treatment that prevents breast cancer by killing the precursor cells that initiate breast cancer," says Lance...
Cancer survivors who self-identified as being lesbian, gay or bisexual were more than twice as likely as heterosexual cancer survivors to have participated in cancer clinical trials, according to data from a small study presented at the Fifth AACR Conference on The Science of Cancer Health...
On average, new treatments perform better in clinical trials only slightly more often than existing treatments, according to a new systematic review published in The Cochrane Library. The fact that experimental treatments are not more effective may seem disappointing, but the authors of the...
Robotherapist 3D, a robot which aids stroke patients' recovery, is to be brought to market by its worldwide patent holder, a spin-off company from the Miguel Hernandez University of Elche (Alicante, Spain). It is the first robot to enable patients to start doing exercises while supine, allowing...
Two studies of a new pill for multiple sclerosis (MS) suggest it may reduce relapses and disability progression in people with the more common, relapsing-remitting form of the neurological condition, which accounts for around 85% of cases. The studies report the results of two phase 3 clinical...
While the U.S. had a slow night filled with semifinals at the track and field Olympic Trials, drama happened at the Jamaican Olympic Trials. Yohan Blake upset world record holder and defending Olympic champion Usain Bolt.
[ Photos: Usain Bolt beaten at Olympic trials ]
Blake ran 100m in...
Gymnastics meets are rarely quiet, but when McKayla Maroney fell badly on her back during warm-ups at the Visa Championships in early June, the only sound that could be heard was the teen-friendly music blasting from the sound system. Though Maroney stood up and gingerly walked from the...
Cancer patients with annual household incomes below $50,000 were less likely to participate in clinical trials than patients with annual incomes of $50,000 or higher, and were more likely to be concerned about how to pay for clinical trial participation. This is the conclusion of a large study...
A naturally-occurring harmless human virus may be able to boost the effects of two standard chemotherapy drugs in some cancer patients, according to early stage trial data published in Clinical Cancer Research. RT3D, trade name Reolysin, is a new drug developed by Oncolytics Biotech Inc with...
According to a new study from the University of Leicester that has been published in the international journal Sociology of Health and Illness, patient information leaflets for cancer trials miss the mark, with patients declaring they are far too long, incomprehensible, and even intimidating...
The first published results of trials using cells derived from human embryonic stem cells appear to show they have passed an initial safety hurdle. In The Lancet this week, researchers report that two nearly blind patients, one with Stargardt's macular dystrophy and the other with dry...
With the increasing demand for eligible study patient populations as well as the need for more cost-efficient clinical development programs, the CEE and CIS region represents an attractive location for pharma companies to conduct clinical trials. However, there are a number of challenges that...
Cancer researchers are developing a catalog of potential targets for novel treatments while they continue to identify genetic mutations powering different cancer subtypes. Recently, the University of Michigan Comprehensive Cancer Center and Michigan Center for Translational Pathology (MCTP)...
In a development that could pave the way for treatment for rare neurological diseases and clues to more common ones, physician-scientists at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center, the University Hospital for Einstein, have secured a grant to...
download the software completely free ? OK well i found this site and it's full of free software's and EVERYTHING ! But I don't exactly know if it's legal to download any of the software on that site.
Better communication is needed around HIV vaccine trials to ensure those in at-risk communities understand the process and continue to participate, according to a new University of Toronto study. The study - published in the September edition of the American Journal of Public Health - centred...